ResMed Inc. (RMD)

109.38
NYSE : Health Technology
Prev Close 109.38
Day Low/High 0.00 / 0.00
52 Wk Low/High 71.29 / 109.69
Avg Volume 634.00K
Exchange NYSE
Shares Outstanding 142.74M
Market Cap 15.55B
EPS 2.40
P/E Ratio 50.92
Div & Yield 1.40 (1.28%)

Latest News

Brightree Announces EReferral Integration With Athenahealth

Brightree Announces EReferral Integration With Athenahealth

Brightree, the leading provider of cloud-based software helping post-acute care companies improve business performance and patient outcomes, announced the release of a new solution that allows home medical equipment (HME) providers to digitally receive...

ResMed Becomes #118 Most Shorted S&P 500 Component, Replacing F5 Networks

ResMed Becomes #118 Most Shorted S&P 500 Component, Replacing F5 Networks

The most recent short interest data has been released for the 05/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

ResMed To Acquire HEALTHCAREfirst, A Cloud-based Software And Services Provider For Home Health And Hospice Agencies

ResMed To Acquire HEALTHCAREfirst, A Cloud-based Software And Services Provider For Home Health And Hospice Agencies

ResMed (NYSE:RMD, ASX:RMD), a global leader in connected healthcare solutions, today announced it has entered into a definitive agreement to acquire privately held HEALTHCARE first, a provider of software solutions and services for home health and hospice...

ResMed Studies Show Remote Monitoring And Automated Resupply Improve Adherence To PAP Therapy

ResMed Studies Show Remote Monitoring And Automated Resupply Improve Adherence To PAP Therapy

Remote patient monitoring and resupply programs have been shown to improve patient adherence to positive airway pressure (PAP) therapy, according to two separate studies presented by ResMed (NYSE: RMD, ASX: RMD) this week at the ATS 2018 International...

Woman Wearing CPAP, The Gold Standard Treatment For Sleep Apnea (Photo: Business Wire)

Woman Wearing CPAP, The Gold Standard Treatment For Sleep Apnea (Photo: Business Wire)

A new data analysis presented by ResMed (NYSE: RMD, ASX: RMD) this week at the ATS 2018 International Conference indicates that the prevalence of sleep apnea impacts more than 936 million people worldwide - nearly 10 times greater than previous estimates.

ResMed-sponsored Studies Show Combining Home Oxygen And Home Non-invasive Ventilation Is A Cost Effective Treatment For COPD

ResMed-sponsored Studies Show Combining Home Oxygen And Home Non-invasive Ventilation Is A Cost Effective Treatment For COPD

ResMed (NYSE: RMD, ASX: RMD) announced today the results of two clinical analyses conducted for the U.

ResMed QuietAir Diffuser Vent Elbow (Photo: Business Wire)

ResMed QuietAir Diffuser Vent Elbow (Photo: Business Wire)

ResMed (NYSE: RMD) (ASX: RMD) today introduced the QuietAir diffuser vent elbow, for its latest continuous positive airway pressure (CPAP) full face masks: AirFit F20 with silicone cushion and AirTouch F20 with memory foam cushion.

ResMed Inc. Announces Results For The Third Quarter Of Fiscal Year 2018

ResMed Inc. Announces Results For The Third Quarter Of Fiscal Year 2018

ResMed (NYSE: RMD) (ASX: RMD) today announced results for its quarter ended March 31, 2018.

Company Profile For ResMed

Company Profile For ResMed

ResMed (NYSE: RMD) (ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath.

Bobby Ghoshal, ResMed Chief Technology Officer (Photo: Business Wire)

Bobby Ghoshal, ResMed Chief Technology Officer (Photo: Business Wire)

ResMed (NYSE: RMD, ASX: RMD) today announced the hire of its first chief technology officer (CTO), Bobby Ghoshal, effective today.

ResMed To Announce Third Quarter Fiscal Year 2018 Results

ResMed To Announce Third Quarter Fiscal Year 2018 Results

ResMed (NYSE: RMD) today announced it will report its third quarter of fiscal year 2018 results on Thursday, April 26, 2018, after the New York Stock Exchange market closes.

ResMed Becomes #12 Most Shorted S&P 500 Component, Replacing Varian Medical Systems

ResMed Becomes #12 Most Shorted S&P 500 Component, Replacing Varian Medical Systems

The most recent short interest data has been released for the 01/12/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

GEMCO Medical Announces Brightree Partnership

GEMCO Medical Announces Brightree Partnership

Providing more Purchasing Power for Providers at no Additional Cost.

Markets Take the Government Shutdown in Their Stride: Market Recon

Markets Take the Government Shutdown in Their Stride: Market Recon

Although equity index futures are lower, this whole thing has been taken in stride. For now.

How to Play Eight Potential Breakout Stocks

How to Play Eight Potential Breakout Stocks

A partial list of names that are showing signs of breaking out Monday.

Short Interest Drops 13.3% For RMD

Short Interest Drops 13.3% For RMD

The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 1,071,731 share decrease in total short interest for ResMed Inc. , to 6,966,017, a decrease of 13.33% since 10/31/2017.

Automated Resupply Enrollment Now Available For HMEs Using Brightree And ResMed's AirView

Automated Resupply Enrollment Now Available For HMEs Using Brightree And ResMed's AirView

Managing compliance for sleep apnea patients and increasing resupply revenue just got easier for home medical equipment (HME) providers, as Brightree today announced automated resupply enrollment for patients managed by...

ResMed Stock Sees Short Interest Decline 11.4%

The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 1,305,275 share decrease in total short interest for ResMed Inc. , to 10,131,531, a decrease of 11.41% since 04/13/2017.

Brightree Expands Sleep Therapy Capabilities With ResMed's AirView Platform

Brightree®, the leading provider of cloud-based software for helping post-acute care companies improve business performance and patient outcomes, today announced that its home medical equipment (HME) billing and...

Here's Why This Rally Is Sustainable: Cramer's 'Mad Money' Recap (Tuesday 1/24/17)

Here's Why This Rally Is Sustainable: Cramer's 'Mad Money' Recap (Tuesday 1/24/17)

Jim Cramer names a few of his favorite things: housing, bank, material and tech stocks, oil, copper and deregulation.

ResMed: Cramer's Top Takeaways

ResMed: Cramer's Top Takeaways

Jim Cramer takes a closer look at ResMed and its future as a medical-device maker focusing on sleep apnea and COPD.

Why CarMax and Garmin Could Be Prime Candidates for a Short Squeeze

Why CarMax and Garmin Could Be Prime Candidates for a Short Squeeze

Short-sellers are feeling the pressure this year, but you don't have to if you take a look at these four stock that could face short squeezes.

Why a Massive Short Squeeze Could Send These 4 Stocks Into Orbit

Why a Massive Short Squeeze Could Send These 4 Stocks Into Orbit

The short trade is crowded in these four big stocks.

National Sleep Survey Results (Graphic: Business Wire)

National Sleep Survey Results (Graphic: Business Wire)

At CES 2017, SleepScore Labs shared exciting new information that will change the way people think about their sleep.

ResMed (RMD) Stock Sharply Lower After Q1 Results Miss Estimates

ResMed (RMD) Stock Sharply Lower After Q1 Results Miss Estimates

ResMed (RMD) reported earnings and revenue that fell short of analysts' expectations for the 2017 fiscal first quarter.

Jim Cramer's Top Takeaways: Dave & Buster's, Starbucks, Chipotle, ResMed

Jim Cramer's Top Takeaways: Dave & Buster's, Starbucks, Chipotle, ResMed

Cramer is concerned about Dave & Buster's but says Chipotle's problems are behind it.

Jim Cramer's 'Mad Money' Recap: The Perils of Competition

Jim Cramer's 'Mad Money' Recap: The Perils of Competition

When it comes to stock prices, competition has a lot of influence, Cramer says.

TheStreet Quant Rating: A (Buy)